{"id":"https://openalex.org/W2018588587","doi":"https://doi.org/10.1007/s00228-008-0475-9","title":"Pharmacovigilance: methods, recent developments and future perspectives","display_name":"Pharmacovigilance: methods, recent developments and future perspectives","publication_year":2008,"publication_date":"2008-06-03","ids":{"openalex":"https://openalex.org/W2018588587","doi":"https://doi.org/10.1007/s00228-008-0475-9","mag":"2018588587","pmid":"https://pubmed.ncbi.nlm.nih.gov/18523760"},"language":"en","primary_location":{"id":"doi:10.1007/s00228-008-0475-9","doi":"https://doi.org/10.1007/s00228-008-0475-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00228-008-0475-9","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2018588587"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027051500","display_name":"Linda H\u00e4rmark","orcid":"https://orcid.org/0000-0002-9314-9298","observed_orcids":["https://orcid.org/0000-0002-9314-9298"]},"institutions":[{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"L. H\u00e4rmark","raw_affiliation_strings":["Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 's-Hertogenbosch, The Netherlands. l.harmark@lareb.nl","Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 's-Hertogenbosch, The Netherlands. l.harmark@lareb.nl","institution_ids":["https://openalex.org/I4210139651"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5062272624","display_name":"A.C. van Grootheest","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]},{"id":"https://openalex.org/I4210139651","display_name":"Netherlands Pharmacovigilance Centre Lareb","ror":"https://ror.org/04fp8ns78","country_code":"NL","type":"facility","lineage":["https://openalex.org/I4210139651"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"A. C. van Grootheest","raw_affiliation_strings":["Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands","Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, \u2019s-Hertogenbosch, The Netherlands","Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacy: Pharmacotherapy and Pharmaceutical Care, University of Groningen, Groningen, The Netherlands","institution_ids":["https://openalex.org/I169381384"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, Goudsbloemvallei 7, 5237 MH, \u2019s-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]},{"raw_affiliation_string":"Netherlands Pharmacovigilance Centre Lareb, \u2019s-Hertogenbosch, The Netherlands","institution_ids":["https://openalex.org/I4210139651"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5027051500"],"corresponding_institution_ids":["https://openalex.org/I4210139651"],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":null,"fwci":2.1583,"has_fulltext":false,"cited_by_count":312,"citation_normalized_percentile":{"value":0.84269663,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"64","issue":"8","first_page":"743","last_page":"752"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10902","display_name":"Complementary and Alternative Medicine Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":1.0},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.9300000071525574},{"id":"https://openalex.org/keywords/spontaneous-reporting","display_name":"spontaneous reporting","score":0.8429999947547913},{"id":"https://openalex.org/keywords/intensive-monitoring","display_name":"intensive monitoring","score":0.6330000162124634},{"id":"https://openalex.org/keywords/pharmacovigilance-databases","display_name":"pharmacovigilance databases","score":0.8360000252723694},{"id":"https://openalex.org/keywords/conditional-approval","display_name":"conditional approval","score":0.9789999723434448},{"id":"https://openalex.org/keywords/risk-management-plan","display_name":"risk management plan","score":0.9980000257492065},{"id":"https://openalex.org/keywords/transparency","display_name":"transparency","score":0.5519999861717224},{"id":"https://openalex.org/keywords/patient-involvement","display_name":"patient involvement","score":0.9869999885559082},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.9620000123977661}],"concepts":[{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.9626814723014832},{"id":"https://openalex.org/C2780233690","wikidata":"https://www.wikidata.org/wiki/Q535347","display_name":"Transparency (behavior)","level":2,"score":0.6272475123405457},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5313568711280823},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5031730532646179},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.47636935114860535},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.4421154260635376},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41030511260032654},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.36927199363708496},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35800427198410034},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3571128845214844},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.34123149514198303},{"id":"https://openalex.org/C55587333","wikidata":"https://www.wikidata.org/wiki/Q1133029","display_name":"Engineering ethics","level":1,"score":0.3270973265171051},{"id":"https://openalex.org/C539667460","wikidata":"https://www.wikidata.org/wiki/Q2414942","display_name":"Management science","level":1,"score":0.32479041814804077},{"id":"https://openalex.org/C56739046","wikidata":"https://www.wikidata.org/wiki/Q192060","display_name":"Knowledge management","level":1,"score":0.32141903042793274},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.21258553862571716},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.12755310535430908},{"id":"https://openalex.org/C38652104","wikidata":"https://www.wikidata.org/wiki/Q3510521","display_name":"Computer security","level":1,"score":0.06851854920387268}],"mesh":[{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D012308","descriptor_name":"Risk Management","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D014944","descriptor_name":"World Health Organization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016208","descriptor_name":"Databases, Factual","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016907","descriptor_name":"Adverse Drug Reaction Reporting Systems","qualifier_ui":"Q000458","qualifier_name":"organization & administration","is_major_topic":true},{"descriptor_ui":"D017891","descriptor_name":"Pharmacoepidemiology","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D064420","descriptor_name":"Drug-Related Side Effects and Adverse Reactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1007/s00228-008-0475-9","doi":"https://doi.org/10.1007/s00228-008-0475-9","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s00228-008-0475-9","pdf_url":null,"source":{"id":"https://openalex.org/S31780008","display_name":"European Journal of Clinical Pharmacology","issn_l":"0031-6970","issn":["0031-6970","1432-1041"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:18523760","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18523760","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire_cris_publications/51469c80-b8de-49dd-984c-d485e6cfa07e","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11370/51469c80-b8de-49dd-984c-d485e6cfa07e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Harmark, L & van Grootheest, A C 2008, 'Pharmacovigilance : Methods, recent developments and future perspectives', European Journal of Clinical Pharmacology, vol. 64, no. 8, pp. 743-752. https://doi.org/10.1007/s00228-008-0475-9","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:rug:oai:pure.rug.nl:publications/51469c80-b8de-49dd-984c-d485e6cfa07e","doi":null,"is_oa":false,"landing_page_url":"https://research.rug.nl/en/publications/51469c80-b8de-49dd-984c-d485e6cfa07e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Clinical Pharmacology, 64(8), 743 - 752. Springer Verlag","raw_type":"info:eu-repo/semantics/other"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":67,"referenced_works":["https://openalex.org/W66332517","https://openalex.org/W123303041","https://openalex.org/W1494561330","https://openalex.org/W1495886729","https://openalex.org/W1506237988","https://openalex.org/W1509507586","https://openalex.org/W1517947046","https://openalex.org/W1519277705","https://openalex.org/W1522960617","https://openalex.org/W1564113732","https://openalex.org/W1571655889","https://openalex.org/W1576358752","https://openalex.org/W1939080369","https://openalex.org/W1963885493","https://openalex.org/W1965992514","https://openalex.org/W1968330079","https://openalex.org/W1972136146","https://openalex.org/W1976587508","https://openalex.org/W1979007546","https://openalex.org/W1979670130","https://openalex.org/W1981809734","https://openalex.org/W1983223343","https://openalex.org/W1989454703","https://openalex.org/W2002367988","https://openalex.org/W2008062554","https://openalex.org/W2008122742","https://openalex.org/W2008291984","https://openalex.org/W2009890917","https://openalex.org/W2011949050","https://openalex.org/W2013123695","https://openalex.org/W2016660390","https://openalex.org/W2017286391","https://openalex.org/W2024874163","https://openalex.org/W2034759761","https://openalex.org/W2037946574","https://openalex.org/W2038021505","https://openalex.org/W2042511069","https://openalex.org/W2043254260","https://openalex.org/W2046672383","https://openalex.org/W2048614992","https://openalex.org/W2064638166","https://openalex.org/W2068959237","https://openalex.org/W2074526889","https://openalex.org/W2075017432","https://openalex.org/W2077881667","https://openalex.org/W2086114039","https://openalex.org/W2090631905","https://openalex.org/W2096459479","https://openalex.org/W2100136291","https://openalex.org/W2113330592","https://openalex.org/W2115624781","https://openalex.org/W2121066811","https://openalex.org/W2127125241","https://openalex.org/W2140742150","https://openalex.org/W2147598330","https://openalex.org/W2151072354","https://openalex.org/W2158131645","https://openalex.org/W2163072178","https://openalex.org/W2281690872","https://openalex.org/W2329828496","https://openalex.org/W2413785097","https://openalex.org/W2418801225","https://openalex.org/W2493942417","https://openalex.org/W2785712856","https://openalex.org/W4210952172","https://openalex.org/W4237909713","https://openalex.org/W4255772105"],"related_works":["https://openalex.org/W7143424770","https://openalex.org/W7162661944","https://openalex.org/W4396808525","https://openalex.org/W6968335873","https://openalex.org/W4246827538","https://openalex.org/W7128601978","https://openalex.org/W7171812512","https://openalex.org/W7214088750","https://openalex.org/W7104506696","https://openalex.org/W7170713343"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":18},{"year":2025,"cited_by_count":18},{"year":2024,"cited_by_count":18},{"year":2023,"cited_by_count":21},{"year":2022,"cited_by_count":16},{"year":2021,"cited_by_count":25},{"year":2020,"cited_by_count":20},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":20},{"year":2014,"cited_by_count":24},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
